Structural studies of loteprednol etabonate and other analogs of prednisolone using NMR techniques

Steroids

Volumn 61, Issue 9, 1996, Pages 524-530

  Rachwal, Stanislaw ^a   Pop, Emil ^a   Brewster, Marcus E ^a  

^a Pharmos Corporation   (United States)

Author keywords

11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate; 13C NMR; 1H NMR; prednisolone analog

Indexed keywords

LOTEPREDNOL ETABONATE; PREDNISOLONE; PREDNISOLONE ACETATE; PREDNISOLONE DERIVATIVE; STEROID;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; ESTERIFICATION; HORMONE DETERMINATION; HORMONE STRUCTURE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

EID: 0030248951     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00090-6     Document Type: Article

References (31)

1. 13C NMR spectra of steroids - a survey and commentary. Org Magn Resvn 8:439-464.
2. 1H NMR spectra of the steroid hormones, their hydroxylated derivatives and related compounds. J Chem Soc [Perkin 2] 1567-1594.
3. 3. Bodor NS (1981). Steroids having antiinflammatory activity. BE 889,563 (Belgian patent). Chem Abstr 97:6651n.
4. 4. Bodor N, Varga M (1990). Effect of a novel soft steroid on the wound healing of rabbit cornea. Exp Eye Res 50:183-187.
5. 5. Druzgala P, Hochhaus G, Bodor N (1991). Soft drugs. 10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate. J Steroid Biochem Mol Biol 38: 149-154.
6. 6. Bodor NS, Kiss-Buris ST, Buris L (1991). Novel soft steroids: effects on cell growth in vitro and on wound healing in the mouse. Steroids 56:434-439.
7. 7. Alberth M, Wu WM, Winwood D, Bodor N (1991). Lipophilicity, solublity and permeability of loteprednol etabonate: a novel soft anti-inflammatory corticosteroid. J Biopharm Sci 2:115-125.
8. 8. Druzgala P, Wu W-M, Bodor N (1991). Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Curr Eye Res 10:933-937.
9. 9. Bodor N, Loftsson T, Wu W-M (1992). Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate. Pharm Res 9:1275-1278.
10. 10. Hochhaus G, Chen LS, Ratka A, Druzgala P, Howes J, Bodor N, Derendorf H (1992). Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs. J Pharm Sci 81:1210-1215.
11. 11. Bartlett JD, Horwitz B, Laibovitz R, Howes JF (1993). Intraocular pressure response to loteprednol etabonate in known steroid responders. J Ocul Pharmacol 9:157-165.
12. 12. Howes JF, Baru H, Vered M, Neumann R (1994). Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation. J Ocul Pharmacol 10:289-293.
13. 13. Loftsson T, Bodor N (1994). The pharmacokinetics and transdermal delivery of loteprednol etabonate and related soft steroids. Adv Drug Delivery Rev 14:293-299.
14. 14. Gonzalez MD, Burton G (1984). A carbon-13 nuclear magnetic resonance study of the 1,4-diene analog of steroid hormones and related steroids. Org Magn Reson 22:586-591.
15. 15. Phillips GH, May PJ (1974). Androstane-17α-carboxylic acids and processes for the preparation thereof. US 3,828,080 (US patent). Chem Abstr 82:31453x.
16. 16. Silverstein RM, Clayton Bassler G, Morrill TC (1981). Spectroscopic Identification of Organic Compounds. John Wiley and Sons, New York.
17. 17. Duax WL, Griffin JF, Rohrer DC (1981). Conformation of progesterone side chain: conflict between X-ray data and force-field calculations. J Am Chem Soc 103:6705-6712.
18. 18. Pniewska B, Anulewicz R, Uszycka-Horawa T (1995). Pol J Chem 69:441-446.
19. 19. Farrant RD, Kirk DN, Mersh JD, Sanders JKM (1983). Recent applications of NMR to the investigation of steroid structures. J Steroid Biochem 19:181-187.
20. 20. Sanders JKM, Hunter BK (1993). Modern NMR Spectroscopy, 2nd Ed. Oxford University Press, New York.
21. 13C couplings. J Magn Reson 57:314-318.
22. 22. Krabbenhoft HO (1979) Homoallyl and cyclopropylcarbinyl carbonium ion formations under strongly basic conditions. J Org Chem 44:4285-4294.
23. 1H J-resolution spectroscopy. Magn Reson Chem 31:90-93.
24. 24. Karplus M (1959). Contact electron-spin coupling of nuclear magnetic moments. J Chem Phys 30:11-15.
25. 25. Karplus M (1963). Vicinal proton coupling on nuclear magnetic resonance. J Am Chem Soc 85:2870-2871.
26. 26. Pachler KGR (1970). Extended Huckel theory MO calculations of proton-proton coupling constants-II. The effects of substituents on vincinal couplings in monosubstituted ethanes. Tetrahedron 27: 187-199.
27. 27. Pachler KGR (1972). The dependence of vicinal proton-proton coupling constants on dihedral angle and substituents. J Chem Soc [Perkin 2] 1936-1940.
28. 28. Haasnoot CAG, De Leeuw FAAM, Altona C (1980). The relationship between proton-proton NMR coupling constants and substituent electronegativities. 1. An empirical generalization of the Karplus equation. Tetrahedron 36:2783-2792.
29. 29. Kover KE, Jiao D, Fang S, Hruby VJ (1993). Conformational analysis of four β-methylphenylalanine stereoisomers in a bioactive peptide by z-filtered relay NMR spectroscopy. Magn Reson Chem 31: 1072-1076.
30. 1H coupling interactions: identification of different pathways by 2D NMR δ-δ correlated spectroscopy. Applications in structural analysis. Magn Reson Chem 25:311-319.
31. 31. Sedee AGJ, Beijersbergen van Henegouwen GMJ, Guijt W, Haansnoot CAG (1985). Conformational analysis of steroids in solution: 17β-hydroxy-19-nor-5α,17α-pregn-20-yn-3-one and its 5β-isomer studied by nuclear magnetic resonance. J Org Chem 50:4182-4187.